Phototoxic or Photoprotective?-Advances and Limitations of Titanium (IV) Oxide in Dermal Formulations-A Review.
Fiche publication
Date publication
mai 2023
Journal
International journal of molecular sciences
Auteurs
Membres identifiés du Cancéropôle Est :
Pr SCHNEIDER Raphaël
Tous les auteurs :
Gackowski M, Osmałek T, Froelich A, Otto F, Schneider R, Lulek J
Lien Pubmed
Résumé
The widespread role of titanium (IV) oxide (TiO) in many industries makes this substance of broad scientific interest. TiO can act as both a photoprotector and photocatalyst, and the potential for its role in both applications increases when present in nanometer-sized crystals. Its sunlight-scattering properties are used extensively in sunscreens. Furthermore, attempts have been made to incorporate TiO into dermal formulations of photolabile drugs. However, the propensity to generate reactive oxygen species (ROS) rendering this material potentially cytotoxic limits its role. Therefore, modifications of TiO nanoparticles (e.g., its polymorphic form, size, shape, and surface modifications) are used in an effort to reduce its photocatalytic effects. This review provides an overview of the potential risks arising from and opportunities presented by the use of TiO in skin care formulations.
Mots clés
dermal formulations, photoprotection, phototoxicity, titanium (IV) oxide
Référence
Int J Mol Sci. 2023 05 2;24(9):